📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Aspreva Pharmaceuticals

1.1 - Company Overview

Aspreva Pharmaceuticals Logo

Aspreva Pharmaceuticals

Headquarter: Canada
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of pharmaceutical solutions focused on identifying, developing and commercializing new indications for approved drugs and drug candidates for underserved patient populations. Headquartered in Victoria, British Columbia, the company uses a collaboration strategy termed 'indication partnering'.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Aspreva Pharmaceuticals

Mitobridge Logo

Mitobridge

HQ: United States Website
  • Description: Provider of small molecule therapeutics that improve mitochondrial function to address diseases with high unmet need. Pipeline includes investigational candidates: ASP0367 for primary mitochondrial myopathies and Duchenne muscular dystrophy, ASP1128 for acute kidney injury, and an NAD+ modulation program targeting aging-related conditions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Mitobridge company profile →
Palvella Therapeutics Logo

Palvella Therapeutics

HQ: United States Website
  • Description: Provider of therapies for abandoned patient populations.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Palvella Therapeutics company profile →
Glycomine Logo

Glycomine

HQ: United States Website
  • Description: Provider of replacement therapies for rare diseases, including GLM101, a mannose-1-phosphate replacement therapy in clinical development for PMM2-CDG that delivers mannose-1-phosphate directly into cells to bypass PMM2 enzyme deficiency, and a Natural History Study, a longitudinal study to understand PMM2-CDG symptoms, progression, and clinical measures and biomarkers for the disease.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Glycomine company profile →
ApcinteX Logo

ApcinteX

HQ: United Kingdom Website
  • Description: Provider of therapies that modulate the anticoagulant APC pathway to treat haemophilia, developing a drug that turns down this pathway to restore normal blood clotting, with potential applicability across all haemophilia types.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ApcinteX company profile →
Casma Therapeutics Logo

Casma Therapeutics

HQ: United States Website
  • Description: Provider of autophagy-based drug discovery and the PHLYT platform that initiates target-specific autophagic degradation of disease targets, including those beyond the ubiquitin-proteasome system, to design new medicines.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Casma Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Aspreva Pharmaceuticals

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Aspreva Pharmaceuticals

2.2 - Growth funds investing in similar companies to Aspreva Pharmaceuticals

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Aspreva Pharmaceuticals

4.2 - Public trading comparable groups for Aspreva Pharmaceuticals

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Aspreva Pharmaceuticals

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Aspreva Pharmaceuticals

What does Aspreva Pharmaceuticals do?

Aspreva Pharmaceuticals is a provider of pharmaceutical solutions focused on identifying, developing and commercializing new indications for approved drugs and drug candidates for underserved patient populations. Headquartered in Victoria, British Columbia, the company uses a collaboration strategy termed 'indication partnering'.

Who are Aspreva Pharmaceuticals's competitors?

Aspreva Pharmaceuticals's competitors and similar companies include Mitobridge, Palvella Therapeutics, Glycomine, ApcinteX, and Casma Therapeutics.

Where is Aspreva Pharmaceuticals headquartered?

Aspreva Pharmaceuticals is headquartered in Canada.

How many employees does Aspreva Pharmaceuticals have?

Aspreva Pharmaceuticals has 1,000 employees 🔒.

When was Aspreva Pharmaceuticals founded?

Aspreva Pharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is Aspreva Pharmaceuticals in?

Aspreva Pharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Aspreva Pharmaceuticals

Who are the top strategic acquirers in Aspreva Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in Aspreva Pharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Aspreva Pharmaceuticals?

Top strategic M&A buyers groups and sectors for Aspreva Pharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Aspreva Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in Aspreva Pharmaceuticals's sector and industry vertical?

Top PE firms investing in Aspreva Pharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Aspreva Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Aspreva Pharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Aspreva Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Aspreva Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Aspreva Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Aspreva Pharmaceuticals?

The key public trading comparables and valuation benchmarks for Aspreva Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Aspreva Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Aspreva Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Aspreva Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Aspreva Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Aspreva Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in Aspreva Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Aspreva Pharmaceuticals